Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Heart Failure, Systolic Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

6 recruiting trials for Heart Failure, Systolic. Eligibility criteria explained in plain English.

TrialFinderData lists 6 Heart Failure, Systolic clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 2 / Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by University of Leeds (1), University of California, San Francisco (1), Hospital District of Helsinki and Uusimaa (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Heart rate optimisation using force frequency data (device, 1 trial), followed by In-person cardiac rehabilitation, Telehealth cardiac rehabilitation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
6
Sponsors

Track Heart Failure, Systolic trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 2 / Phase 3NCT04201015

Optimising Pacing for Contractility 2

The investigators have demonstrated that they can reliably identify an optimum heart rate range for contractility of the left ventricle in patients with chronic heart failure...

Sponsor: University of LeedsEnrolling: 4001 location
RECRUITINGNCT05933083

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling....

Sponsor: University of California, San FranciscoEnrolling: 5165 locations
RECRUITINGNCT05632432

Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery

Ischemic heart disease (IHD) leads the global mortality statistics. Atherosclerotic plaques in coronary arteries hallmark IHD, drive hypoxia, and may rupture to result in...

Sponsor: Hospital District of Helsinki and UusimaaEnrolling: 501 location
RECRUITINGNCT06324682

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

The goal of this observational study is to evaluate the clinical characteristics of patients undergoing permanent cardiac pacing and to compare procedural efficacy and safety of...

Sponsor: University Hospital of FerraraEnrolling: 840020 locations
RECRUITINGNCT06009276

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

The purpose of the study is to determine associations between fitness status, bacteria in the mouth, and the blood flow to muscle. This study is trying to find out if fitness...

Sponsor: University of VirginiaEnrolling: 701 location
RECRUITINGNCT04950218

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether...

Sponsor: Herlev and Gentofte HospitalEnrolling: 10001 location

Frequently Asked Questions

There are currently 6 clinical trials for Heart Failure, Systolic, with 6 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Heart Failure, Systolic, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Heart Failure, Systolic, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.